Thats exactly what i have been preaching. Positive ponatnib updates will not do much impact to this stock anymore. An nda filling (maybe fast tracked), and/or an fda approval, a buyout offer etc. Those are some examples that I can see in the near future, that will have an impact on this stock going forward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.